Search results
Earnings call: Movano Health Q1 2024 earnings focus on Evie Ring, FDA progress
Investing.com· 11 hours agoThe company showcased the ongoing development of its Evie Ring, a key product in its portfolio, and...
Bristol Myers (BMY) Gets FDA Nod for Breyanzi Label Expansion
Zacks via Yahoo Finance· 3 hours agoBristol Myers Squibb (BMY) obtains FDA approval for the label expansion of CAR T cell therapy...
Karius snares FDA breakthrough tag for genomic infectious disease blood test
FierceBiotech· 4 hours agoAfter picking up $100 million in venture capital cash earlier this month, Karius is adding another...
FDA said it never inspected dental lab that made controversial AGGA device
Medical Xpress· 5 hours agoThe FDA never inspected Johns Dental Laboratories during more than a decade in which it made the...
FDA recalls Abbott’s HeartMate 3 ventricular assist device after 2 deaths
Medical Device Network via Yahoo Finance· 3 hours agoThe US Food and Drug Administration (FDA) has tagged a recall of Abbott’s HeartMate 3 left...
Earnings call: Eyenovia reports Q1 2024 results, focuses on product pipeline By Investing.com
Investing.com· 17 minutes agoEyenovia, Inc. (NASDAQ:EYEN), a biopharmaceutical company specializing in ophthalmic diseases,...
Agenus sets FDA meeting for cancer therapy path By Investing.com
Investing.com· 2 hours agoThe meeting will address the results of botensilimab and balstilimab (BOT/BAL) studies for patients...
FDA report highlights need to improve diversity in clinical trials
Clinical Trials Arena via Yahoo Finance· 5 hours agoThe US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) is...
Posts Claim Falsely That AstraZeneca Is Withdrawing Its COVID Vaccine Because of Blood Clots
The Dispatch via Yahoo News· 46 minutes agoAstraZeneca opted to withdraw its application for FDA approval in November 2022. AstraZeneca vaccine...
FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing
Zacks via Yahoo Finance· 1 day agoPer the FDA, the data submitted by Ascendis (ASND) for its hormone replacement therapy constitutes a...